Endovascular magnetic method for targeted drug delivery
OwnerAlexander G. Viller, Andrey Buryakovinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerAlexander G. Viller, Andrey Buryakovinventors
Estimating the term…
The method for endovascular magnetic targeting drug delivery in a vascular wall and adjoining tissues, wherein an endovascular mesh stent with paramagnetic properties is preliminary implanted in the area of interest by a catheter, a polymeric magneto-responsive carrying agent in the form of particles, containing a drug, is injected, and a magnetic field is applied, characterized in that, at least, one temporary catheter is introduced in the right atrium, and/or in ventricles of heart, and/or in a coronary sinus and/or in a coronary vein, which distal end takes a position close to the implanted mesh stent, thereupon, a gradient permanent magnetic field is generated and adjusted by means of a permanent magnet and/or a solenoid with the core, connected to an electric power source, which magnet or solenoid are located at the distal end of each temporary catheter, where the maximal gradient of magnetic field is located in the implanted endovascular stent, principally on the stent mesh.
A method for endovascular magnetic targeting drug delivery in a vascular wall and adjoining tissues, comprising:
A kit for endovascular magnetic targeting drug delivery in a vascular wall and adjoining tissues, comprising:
Dependencies are inferred from the claim text.